Disparities in Reported Testing for 1p/19q Codeletion in Oligodendroglioma and Oligoastrocytoma Patients: An Analysis of the National Cancer Database
PurposeA chromosomal 1p/19q codeletion was included as a required diagnostic component of oligodendrogliomas in the 2016 World Health Organization (WHO) classification of central nervous system tumors. We sought to evaluate disparities in reported testing for 1p/19q codeletion among oligodendrogliom...
Enregistré dans:
Auteurs principaux: | Jad Zreik, Panagiotis Kerezoudis, Mohammed Ali Alvi, Yagiz U. Yolcu, Sani H. Kizilbash |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5f92be18a923439d93f50d77c72a2060 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Oligodendroglioma anaplásico quístico: Reporte de caso
par: Illescas C.,Javier, et autres
Publié: (2020) -
Case Report: Detection of Symptomatic Treatment-Related Changes in a Patient With Anaplastic Oligodendroglioma Using FET PET
par: Elena Katharina Bauer, et autres
Publié: (2021) -
Gliomas de bajo grado: Viejas controversias, nuevas evidencias
par: Valenzuela M.,Raúl
Publié: (2005) -
Persistent racial disparities in cervical cancer screening with Pap test
par: Cassidi C. McDaniel, et autres
Publié: (2021) -
Development and Validation of an Efficient MRI Radiomics Signature for Improving the Predictive Performance of 1p/19q Co-Deletion in Lower-Grade Gliomas
par: Quang-Hien Kha, et autres
Publié: (2021)